Want to see IN:INDRAMEDCO full AI Analyst Report?

Indraprastha Medical Corporation Limited (INDRAMEDCO) Price & Analysis

6 Followers

INDRAMEDCO Stock Chart & Stats

₹456.05

-₹15.75(-2.78%)

At close: Jan 08 4:00 PM EST

₹456.05

-₹15.75(-2.78%)

Day’s Range― - ―

52-Week Range₹342.35 - ₹640.05

Previous CloseN/A

Volume350.29K

Average Volume (3M)26.01K

Market Cap

₹33.26B

Enterprise Value₹31.81K

Total Cash (Recent Filing)₹2.63B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)17.7

Beta1.62

Next Earnings

Oct 30, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.1%

Share Statistics

EPS (TTM)20.51

Shares Outstanding91,673,000

10 Day Avg. Volume12,545

30 Day Avg. Volume26,009

Financial Highlights & Ratios

PEG Ratio1.32

Price to Book (P/B)4.61

Price to Sales (P/S)2.30

P/FCF Ratio26.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)22.6

Revenue Forecast (FY)₹15.77B

Bulls Say, Bears Say

Bulls Say

Revenue GrowthThe multi-year revenue increase indicates sustained expansion in hospital services and patient activity. Positive growth in each of the last five years supports the durability of the operating model, although the latest annual growth rate moderated.

Profitability RecoveryThe substantial improvement in net and EBIT margins shows that revenue is converting into materially stronger earnings. This creates greater resilience and reinvestment capacity, provided the company can sustain operating efficiency and manage cost and case-mix swings.

Low LeverageVery low leverage and a significantly expanded equity base provide financial flexibility for hospital operations, maintenance investment, and potential growth initiatives. Limited debt dependence also reduces balance-sheet risk if healthcare demand or margins become less favorable.

Bears Say

Slowing Revenue GrowthAlthough revenue has grown consistently over several years, the latest slowdown suggests the company may be approaching a more mature growth phase or facing capacity, pricing, or volume constraints. Sustained deceleration could limit future operating leverage and earnings expansion.

Gross Margin VolatilityLarge changes in gross margin indicate exposure to shifts in clinical mix, consumable costs, pricing, or service economics. Even with stronger EBIT margins, recurring gross-margin volatility can make profitability less predictable and complicate long-term planning.

Cash Flow VolatilityCash generation is strong overall, but year-to-year fluctuations suggest working-capital movements or uneven spending requirements. Such variability can affect the timing of reinvestment, distributions, and liquidity planning, despite the company’s improving cash profile.

INDRAMEDCO FAQ

What was Indraprastha Medical Corporation Limited’s price range in the past 12 months?

Indraprastha Medical Corporation Limited lowest stock price was ₹342.35 and its highest was ₹640.05 in the past 12 months.

What is Indraprastha Medical Corporation Limited’s market cap?

Indraprastha Medical Corporation Limited’s market cap is ₹33.26B.

When is Indraprastha Medical Corporation Limited’s upcoming earnings report date?

Indraprastha Medical Corporation Limited’s upcoming earnings report date is Oct 30, 2026 which is in 40 days.

How were Indraprastha Medical Corporation Limited’s earnings last quarter?

Indraprastha Medical Corporation Limited released its earnings results on Aug 06, 2026. The company reported ₹6.09 earnings per share for the quarter.

Is Indraprastha Medical Corporation Limited overvalued?

According to Wall Street analysts Indraprastha Medical Corporation Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Indraprastha Medical Corporation Limited pay dividends?

Indraprastha Medical Corporation Limited pays a Annually dividend of ₹4 which represents an annual dividend yield of 1.1%. See more information on Indraprastha Medical Corporation Limited dividends here

What is Indraprastha Medical Corporation Limited’s EPS estimate?

Indraprastha Medical Corporation Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Indraprastha Medical Corporation Limited have?

Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding.

What happened to Indraprastha Medical Corporation Limited’s price movement after its last earnings report?

Indraprastha Medical Corporation Limited reported an EPS of ₹6.09 in its last earnings report. Following the earnings report the stock price went down -1.628%.

Which hedge fund is a major shareholder of Indraprastha Medical Corporation Limited?

Currently, no hedge funds are holding shares in IN:INDRAMEDCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited (IMCL) is a prominent Indian healthcare provider, delivering a broad spectrum of hospital services across the nation. The company offers comprehensive medical and surgical solutions across an extensive range of specialties. Its offerings encompass areas like anesthesiology, pediatrics, elder care, genomic medicine, preventative health checks, and a variety of complex surgical interventions, including bariatric, metabolic, bone marrow, cardiac, endovascular, laparoscopic, robotic, spine, pediatric urology, pediatric surgery, transplant, and urology and andrology. Furthermore, IMCL provides specialized medical departments for cancer, cardiology, dermatology, dietetics and clinical nutrition, emergency care, endocrinology/diabetes, ENT, fetal medicine, gastroenterology and hepatology, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedics, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, and transfusion medicine. In addition to its core hospital services, IMCL also operates dedicated cosmetic and dental clinics. Established in 1988, the corporation is headquartered in New Delhi, India.